share_log

Needham Reiterates Hold on Lexicon Pharmaceuticalsto Hold

Benzinga ·  Dec 23 19:56

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) from Hold to Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment